Given a document and an entity the task is to select the author's sentiment towards the entity. Sentiments can be Positive, Neutral and Negative. Select Positive if the article expresses a positive view towards the given entity or praises its quality or skills. Select Neutral if the document expresses no clear view towards the entity or has equal amounts of positive and negative statements or expressing some fact/quote by someone else. Select Negative if the article expresses a negative view towards like harsh remarks, criticizing entities action/decision etc. Note that URLs in the text have been replaced with [Link].

[Q]: What is the sentiment of the following document towards the entity Eddie Montgomery ? Following the tragic death of  his  musical collaborator and bandmate   Eddie Montgomery  is opening up for one of the first times about what the future holds and how  he  remembers  his  dear friend  Troy Gentry.
Since 1999 the group made music together under the moniker of Montgomery Gentry. Speaking to People in its upcoming issue   Montgomery  revealed that the duo had previously discussed what to do if one of them passed away before the other. The 54-year-old explained that they both agreed to keep the band going  no matter what.
âItâs weird  I always thought it was going to be me that went down first â  he  told the outlet.
âA little piece of my soul got lost there â  Montgomery   told People. âIt was a horrific day  my world changed as much as the band did. Itâs something that you never get over. Itâs going to be in my mind and my soul for the rest of my life.â
[A]: Positive


[Q]: What is the sentiment of the following document towards the entity Christopher Robateau ? Lt.  Christopher Robateau  49   was on his way to work when he spotted the beleaguered driver on the side of the highway near Exit 14 in Newark about 6:30 a.m.  city officials said.
 Robateau  was out of  his  vehicle when a car slammed into  him  in the northbound lane just past the exit for Newark Airport.  He  was pronounced dead at the scene  said New Jersey State Police Sgt. Lawrence Peele.
#JerseyCity Police Lt.  Chris Robateau  is donating blood for those who lost their lives on 9/11 14 years ago today. pic.twitter.com/TW2uAGYIYJ â Beth K. Toll (@Volgirl82) September 11  2015
The driver who struck  Robateau  was cooperating with authorities. No charges were initially filed as state troopers probed the crash  Peele said.
A married father of three   Robateau  joined the force in 1994  city officials said.
âHe was one of my finest students â Rich Boggiano  a councilman and retired police detective who taught  Robateau  at the police academy  told NJ.com. âHe was a good person.â
[A]: Neutral


[Q]: What is the sentiment of the following document towards the entity Jenny Chang ? A few years ago he began working with Dr. Jenny Chang  medical director of the Lester and Sue Smith Breast Center at Baylor College of Medicine.
 Chang had performed a number of biopsies on breast cancer patients  both on those whose cancers were confined to the breast and on those whose cancers had metastasized to the brain.
 From those biopsies  Chang said she had identified a number of genetic pathways ways in which gene mutations affected the ability of the cancer to spread unique to patients who developed metastatic breast cancer.
 "But I had a lot of trouble with the data and trying to translate it into clinical practice " she said. She couldn't find her way out from beneath the avalanche of data.
 So she turned to Wong.
 Using his mathematical modeling  Wong sifted through Chang's data and the large databases of genome and clinical trial data. Out of that  he identified several candidate drugs to impair the genetic pathways that helped the cancer spread.
Chang's data and the large databases of genome and clinical trial data. Out of that  he identified several candidate drugs to impair the genetic pathways that helped the cancer spread.
 One of them  a drug named sunitinib  which treats a kidney cancer called renal cell carcinoma  emerged as the best bet. Chang then tested the drug in mice  and the study showed it prevented breast cancer from spreading to the brain.
 She has already begun a Phase II clinical trial of the drug  enrolling nine patients with metastatic breast cancer  and she is looking for more.
 "The drug is very well-tolerated by patients  and so far the trial is going very well " Chang said.
 But by using an existing drug  Chang and Wong could skip the lengthy Phase I  during which a drug is checked for safety. If Chang's tests go well  sunitinib could be on the market within a few years for metastatic breast cancer.
[A]:
Positive